Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Bourdow Carrie L., Chairman & CEO. Insider active across 3 companies, notably TREVENA INC. In total, 20 reports have been published. Split: 2 buys · 3 sells. Total volume traded: €172k. Activity tracked since 28 June 2021. The latest transaction was filed on 8 October 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
56,200 shares@ US$1.78926.5% of flowCommon StockSEC:0001192482-21-000576:0
Ideal exit: 25 Mar 2022 (T+270)
20 of 20 declarations
About Bourdow Carrie L.
Carrie L. Bourdow is President and CEO of TREVENA INC, Nabriva Therapeutics plc, and Sesen Bio, Inc. She plays a key role in the strategic direction of these companies, participating in key decisions that influence their development. Her expertise in the biopharmaceutical sector is valuable to the boards, enabling these companies to navigate effectively in a competitive environment.